Tri-specific binding molecules

US12275798B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Paul Adam · Wien, AT
• Stephen R. Comeau · Avon, US
• Philip Nicholas Gorman · Prospect, US
• Pankaj Gupta · Scarsdale, US
• Priyanka GUPTA · Danbury, US
• Karl-Heinz Heider · Stockerau, AT
• Srinath Kasturirangan · Gaithersburg, US
• Renate Konopitzky · Bad Vöslau, AT
• Klaus-Peter Kuenkele · Perchtoldsdorf, AT
• Sandeep Kumar · Sunnyvale, US
• Taneisha Ann-Tanara MACK · Southbury, US
• Elinborg Ostermann · Mauerbach, AT
• Abdulsalam SHAABAN · Ridgefield, US
• David Weismann · Mödling, AT
• Andreas WERNITZNIG · Wien, AT
• David S. F. Young · Toronto, CA

Key dates

• Filing date: Jun 15, 2022
• Grant date: Apr 15, 2025
• Expiry date: Sep 10, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/94
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates to novel tri-specific binding molecules. The invention also relates to nucleic acids encoding such binding molecules; to methods for preparing such binding molecules; to host cells expressing or capable of expressing such binding molecules; to compositions comprising such binding molecules; and to uses of such binding molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.